Shah Capital, Novavax's second-largest shareholder, is pressing the biotech's board to pursue strategic changes, including a ...
Stocktwits on MSN
Novavax Stock Faces Retail Backlash As Shah Capital Warns Of Proxy Fight And Presses For A Sale
Shah Capital increased its stake to about 8.3% and said the gap between Novavax’s scientific potential and its commercial ...
In his new book, 'Fair Doses,' epidemiologist Seth Berkley discusses what went right -- and wrong -- with COVID vaccine distribution and whether the world is ready if a new pandemic were to strike.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback